Page 1 of Clinical Trials for Drug Radium-223 chloride Alpharadin, 10 Total Matches
- 1RecruitingLast Updated: May 11, 2012Condition(s): Bone Metastases; Castration-Resistant Prostate Cancer
- 2CompletedLast Updated: September 8, 2010Condition(s): Hormone Refractory Prostate Cancer; Bone Metastases
- 3RecruitingLast Updated: May 23, 2012Condition(s): Prostatic Neoplasms
- 4Active, not recruitingLast Updated: September 28, 2011Condition(s): Hormone Refractory Prostate Cancer; Bone Metastases
- 5AvailableLast Updated: May 22, 2012Condition(s): Prostatic Neoplasms
- 6CompletedLast Updated: June 8, 2011Condition(s): Hormone Refractory Prostate Cancer; Bone Metastases
- 7CompletedLast Updated: September 8, 2010Condition(s): Prostate Cancer; Neoplasm Metastasis
- 8CompletedLast Updated: October 4, 2011Condition(s): Prostate Cancer; Metastases; Pharmacokinetics
- 9Active, not recruitingLast Updated: October 4, 2011Condition(s): Breast Cancer; Bone Metastases
- 10CompletedLast Updated: September 8, 2010Condition(s): Prostate Cancer; Neoplasm Metastasis
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Radium-223+chloride+Alpharadin
